Company news
Relay Therapeutics, Inc. news in 2022
Relay Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
November 2, 2022
Relay Therapeutics to Announce Third Quarter 2022 Financial Results and Corporate Highlights
October 26, 2022
Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Precision Oncology Conference
September 25, 2022
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
September 11, 2022
Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOne®CDx as a Companion Diagnostic for Relay’s Investigational FGFR2 Inhibitor, RLY-4008
September 11, 2022
Late Breaking Data Presented at ESMO Congress 2022 Demonstrate Potential of RLY-4008 to Transform Treatment Options for Cholangiocarcinoma Patients with FGFR2-Driven Disease
September 10, 2022
Relay Therapeutics to Present Clinical Data on RLY-4008 at ESMO Congress
August 17, 2022
Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
August 3, 2022
Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights
July 27, 2022
Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangiocarcinoma and Growing Breast Cancer Franchise at Virtual Analyst and Investor Event
June 26, 2022
Relay Therapeutics Announces Timing of Virtual Analyst and Investor Event
June 15, 2022
Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
May 4, 2022
Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Healthcare Conference
May 2, 2022
Relay Therapeutics to Announce First Quarter 2022 Financial Results and Corporate Highlights
April 27, 2022
Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
February 23, 2022
Relay Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
February 16, 2022
Relay Therapeutics Announces Dosing of First Patient in First-in-Human Trial of RLY-2608 and Initiation of Expansion Cohorts for First-In-Human Trial of RLY-4008
January 3, 2022
Relay Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
January 2, 2022
Decks in 2022
- ESMO Congress 2022
Conference · 27 slides · Sep 12, 2022
- Investor Day (June 2022)
Investor day · 50 slides · Jun 27, 2022
- 40th Annual J.P. Morgan Healthcare Conference (January 2022)
Conference · 43 slides · Jan 10, 2022